The occurrence and genetic variability of Candida parapsilosis isolates in two Hungarian hospitals, located in Debrecen and Pé cs, were examined. Among the 209 Candida isolates examined, 20 were found to belong to C. parapsilosis sensu lato, based on morphological, physiological and molecular data. The frequency of occurrence of C. parapsilosis isolates (9.6 %) was lower than that observed in Europe but higher than that observed previously in Hungary. The genetic variability of C. parapsilosis sensu lato isolates was also examined using random amplified polymorphic DNA (RAPD) analysis and sequence analysis of the intergenic transcribed spacer (ITS) region of the rRNA gene cluster. The genetic variability of the isolates was relatively high, as revealed by RAPD analysis. Two isolates were found to belong to the recently described Candida metapsilosis species (C. parapsilosis group III), based on ITS sequence data, RAPD analysis and phenotypic data. These two isolates could also be distinguished from C. parapsilosis sensu stricto isolates using a primer pair developed for the detection of C. parapsilosis group I isolates. To the best of the authors' knowledge, this is the first report on the identification of C. metapsilosis from bloodstream infection.
INTRODUCTION
Infections caused by Candida species are widespread throughout the world. Although Candida albicans is the most common Candida species encountered as a cause of human infection, other Candida species have been increasingly associated with disseminated disease since the 1990s. Among them, C. parapsilosis has been the second most common yeast species isolated from bloodstream infections in several surveys (Safdar et al., 2002; Messer et al., 2006; Bassetti et al., 2006) . This species has emerged as an important nosocomial pathogen, with clinical manifestations that include fungaemia, endocarditis, endophthalmitis, septic arthritis and peritonitis, and infection usually occurs in association with invasive procedures or prosthetic devices (Weems, 1992) . In some children's hospitals, C. parapsilosis has become the predominant species causing candidaemia (Levy et al., 1998) . This species is more frequent in bloodstream infections of neonates, in transplant recipients and in patients who have received parenteral nutrition or previous antifungal therapy (Almirante et al., 2006) . This species is also frequently associated with catheter-associated candidaemia and intravenous hyperalimentation (Kremery & Barnes, 2002) .
Previous studies have clarified that C. parapsilosis sensu lato isolates can be divided into three groups that can be Abbreviations: ITS, intergenic transcribed spacer; RAPD, random amplified polymorphic DNA.
The GenBank/EMBL/DDBJ accession numbers for the ITS sequences of C. metapsilosis 12821 and Bp57 are DQ786952 and DQ786953, respectively.
Neighbour-joining tree-based ITS sequence data of the examined Candida isolates are available as supplementary data with the online version of this paper.
distinguished based on several criteria, including randomly amplified polymorphic DNA (RAPD) analysis (Lehmann et al., 1992) , isoenzyme electrophoresis (Lin et al., 1995) , sequences of the internal transcribed spacer (ITS) region of the rRNA gene cluster (Lin et al., 1995; Pryce et al., 2006) , hybridization to a fingerprinting probe (Enger et al., 2001) , DNA relatedness (Roy & Meyer, 1998) , morphotyping (Cassone et al., 1995) , electrophoretic karyotypes (Lott et al., 1993) , single nucleotide polymorphisms (Fundyga et al., 2004) , mitochondrial DNA sequence differences (Nosek et al., 2002; Kosa et al., 2006) and biofilm-producing abilities (Song et al., 2005) . Recently, Tavanti et al. (2005) have recognized C. parapsilosis groups II and III as separate species, Candida orthopsilosis and Candida metapsilosis, respectively, based on multilocus sequence typing studies. Accordingly, C. parapsilosis sensu lato includes C. parapsilosis sensu stricto and the two newly described species. The two latter species are recovered relatively rarely in clinical samples (Tavanti et al., 2005) . In addition, C. parapsilosis group IV has also been recognized recently among Brazilian clinical Candida isolates by Iida et al. (2005) .
In this study, we examined the occurrence of C. parapsilosis isolates among Candida isolates collected in Hungarian hospitals, and examined the genetic variability of these isolates using sequence analysis of the ITS region and the RAPD technique.
METHODS
Clinical samples. Altogether, 209 Candida isolates from blood samples from two Hungarian hospitals, located in Debrecen and Pécs, were examined. All examined isolates came from different patients. C. parapsilosis isolates were identified by standard morphological and physiological methods within the hospitals (Barnett et al., 2000) .
Phenotypying. The API 20C AUX version 3.0 kit (bioMérieux) was used to type the species. Isolates from stored slants were streaked onto nutrient agar and incubated at 30 uC for 24 and 48 h. Samples were then analysed according to the manufacturer's prescribed methods. The antifungal susceptibilities of isolates were determined by the Etest method (AB Biodisk). The Etest was performed in accordance with the manufacturer's instructions, with the use of Casitone agar plates (AB Biodisk, 2003) . A 0.5 McFarland turbidity suspension was used as a standard in the test. The drug concentrations of Etest strips were 0.016-256 mg l 21 for fluconazole, and 0.002-32 mg l 21 for itraconazole, voriconazole and amphotericin B. The incubation time was 24-48 h at 30 uC, depending on the growth characteristics. The MICs for amphotericin B were taken as the drug concentrations causing 100 % inhibition. MICs for azoles were read at the visually selected end point of 80 % inhibition of growth. Interpretative susceptibility criteria for these antifungal agents were used as published by the Clinical and Laboratory Standards Institute (CLSI) and in the literature (National Committee for Clinical Laboratory Standards, 2002; de Hoog et al., 2000) .
Genotyping. Isolates were cultivated in YPD medium (0.5 % Bacto yeast extract, 1 % glucose, 0.5 % Bacto peptone) and centrifuged, and DNA was extracted from the cells using the Masterpure yeast DNA purification kit (Epicentre Biotechnologies) according to the instructions of the manufacturer. For confirmation of the species assignment of the isolates, the species-specific primer pair developed for C. parapsilosis by Luo & Mitchell (2002) was used.
For the identification of C. parapsilosis sensu stricto (group I) isolates, the primer pair developed by Pontieri et al. (2001) was applied. The ITS region of the isolates was amplified using primers ITS1 and ITS4 (White et al., 1990) . DNA fragments were purified from the excised agarose blocks using Genelute spin columns (Sigma-Aldrich). Direct sequencing of the fragments was performed on an ABI 373A DNA sequencer (Applied Biosystems) using dideoxy terminator reaction chemistry. Sequences were determined from both strands using ITS1 and ITS4 as primers. The GenBank accession numbers for the ITS sequences of C. metapsilosis 12821 and Bp57 are DQ786952 and DQ786953, respectively. RAPD analysis of the isolates was carried out according to the literature (Williams et al., 1990) . Fungal DNA sequences were amplified by using the following decamer primers of the Operon random primer kit ( Data analysis. Sequence alignments were performed by using CLUSTAL_X (Thompson et al., 1997) and improved manually. Evolutionary distances between the sequences were calculated by Kimura's formula (Kimura, 1980) using the program DNADIST. Phylogenetic trees were prepared by the neighbour-joining method (Saitou & Nei, 1987) using the program NEIGHBOR of the PHYLIP package. Bootstrap values were calculated from 1000 replications of the bootstrap procedure using programs SEQBOOT, DNADIST, NEIGHBOR and CONSENSE of the package (Felsenstein, 1995) . RAPD bands were scored visually. Only those bands were taken into account which were amplified in all three separate RAPD reactions. The binary matrices of RAPD data were converted to distance matrices using PhylTools (Buntjer, 1997) . RAPD data were analysed by the neighbour-joining method using the program NEIGHBOR of the PHYLIP package (Saitou & Nei, 1987; Felsenstein, 1995) .
RESULTS AND DISCUSSION

Occurrence of C. parapsilosis in Hungarian hospitals
Altogether, 103 and 106 Candida isolates were collected in two Hungarian hospitals located in Debrecen and Pécs, respectively, during 2004-2005 . Among these, 10 and 16 isolates, respectively, were found to belong to C. parapsilosis sensu lato, based on morphological and physiological criteria ( Table 1 ). The C. parapsilosis species-specific primer pair (Luo & Mitchell, 2002) was successfully used to confirm the identity of eight and 12 isolates as C. parapsilosis sensu lato. API 20C AUX tests also confirmed that these isolates belonged to C. parapsilosis sensu lato. Overall, 9.6 % of the collected isolates were found to belong to C. parapsilosis sensu lato, while the remaining isolates were found to belong to C. albicans, Candida lusitaniae (teleomorph Clavispora lusitaniae; Kurtzman & Fell, 1998) or Candida krusei (teleomorph Issatchenkia orientalis; Kurtzman & Fell, 1998) (Table 1) . This observation could have been caused by misidentifications or, more probably, by contamination of some of the cultures during storage of the isolates after morphological identification.
Previously, C. parapsilosis has been found to be responsible for about 19 % of bloodstream Candida infections in Europe . More recent surveys have revealed that C. parapsilosis is responsible for more than 20 % of candidaemias in Italy (Bassetti et al., 2006; Bedini et al., 2006) , Spain (Almirante et al., 2006; Rodriguez et al., 2006; San Miguel et al., 2006) and South American countries (Brito et al., 2006; Rodero et al., 2005) , while this species is encountered less frequently in Turkey (12.5 %; Yapar et al., 2006) and Norway (6 %; Sandven et al., 2006) . In a worldwide survey, Messer et al. (2006) have found C. parapsilosis to be responsible for candidaemias in 16.36 % of the 336 cases examined from Europe. In another survey, Tortorano et al. (2004 Tortorano et al. ( , 2006 have found that C. parapsilosis is responsible for 6.9-30 % (mean 13.54 %) of candidaemias in different European countries, with the highest incidence found in Spain. In a previous study, Dó czi et al. (2002) found that C. parapsilosis was responsible for 4.9 % of bloodstream infections caused by Candida species in a university hospital in Hungary. These data indicate that the frequency of C. parapsilosis infections varies widely among different institutions and countries . The 9.6 % incidence of this species found in this survey is higher than that observed previously in Hungary, but lower than the mean observed in European countries.
Genetic variability of C. parapsilosis isolates RAPD analysis of the isolates was carried out by using 21 random decamer primers. The genetic variability observed among the isolates was low: most isolates exhibited very similar or the same RAPD patterns with most primers tested (Fig. 1) . Similarly low genetic variability has been observed among C. parapsilosis sensu stricto isolates by Zeng et al. (1996) , Lehmann et al. (1992) and Enger et al. (2001) . For preparation of the similarity matrix, the presence or absence of 72 DNA bands was taken into account. The dendrogram based on RAPD data indicates that the C. parapsilosis isolates form two main clusters which are supported by high bootstrap values (Fig. 2) . One of these includes two isolates, 12821 and Bp57, which could also be distinguished from other C. parapsilosis isolates using the C. parapsilosis group I-specific primer pair developed by Pontieri et al. (2001) . This primer pair did not amplify the expected product from isolates 12821 and Bp57 (data not shown).
Sequences of the ITS region of the isolates were also determined. Phylogenetic analysis of sequence data indicated Blood, Pécs C. krusei that two of the isolates that belonged to C. parapsilosis sensu lato were members of the C. metapsilosis species (see Supplementary Fig. S1 ). In other studies, C. metapsilosis has been identified in the USA, Japan, Brazil, Norway and Belgium (Enger et al., 2001; Rycovska et al., 2004; Iida et al., 2005; Tavanti et al., 2005) . To the best of our knowledge, the present study is the first report on the occurrence of this species in Central Europe. In addition, in this study, C. metapsilosis was isolated from a bloodstream infection for the first time. The results of the API 20C AUX tests also indicated that these two isolates belonged to the C. metapsilosis species, since in a similar manner to the results of Lin et al. (1995) , the two isolates could grow on D-xylitol, in contrast to the C. parapsilosis sensu stricto isolates (data not shown). (Lin et al., 1995; Rex et al., 1995; Pfaller et al., 2001; Lu et al., 2004; St-Germain et al., 2001; Tortorano et al., 2004 Tortorano et al., , 2006 de Hoog et al., 2000) . The MIC values obtained for C. metapsilosis isolates fell within the range of MICs of C. parapsilosis isolates (data not shown). C. metapsilosis isolates exhibited lower mean MIC values for voriconazole and amphotericin B than C. parapsilosis isolates. Similarly, lower MIC values have been observed for amphotericin B in C. metapsilosis than in C. parapsilosis in earlier studies (Lin et al., 1995) .
Antifungal susceptibility tests
However, further isolates should be examined to draw definite conclusions.
In conclusion, 9.6 % of Candida infections were found to be caused by C. parapsilosis sensu lato in our survey of two Hungarian hospitals. Two of these isolates were found to belong to the recently described C. metapsilosis species. This is believed to be the first report on the identification of C. metapsilosis from bloodstream infection. Further studies are in progress to identify the rest of the Candida isolates using molecular and phenotypic data, and to survey other Hungarian hospitals for the presence of C. metapsilosis. Fig. 1 . RAPD profiles of the examined C. parapsilosis sensu lato isolates generated by primer OPR-15. Lanes: 1, 100 bp DNA ladder; 2, C. parapsilosis 5312; 3, C. parapsilosis 5308; 4, C. parapsilosis Bp73; 5, C. parapsilosis Bp46; 6, C. parapsilosis 25329; 7, C. parapsilosis Bp42; 8, C. metapsilosis 12821; 9, C. metapsilosis Bp57; 10, C. krusei Bp47; 11, 1 kb DNA ladder. 
